Primary cutaneous melanoma;Melanoma cutâneo primário

Revista da Associacao Medica Brasileira

Volumn 51, Issue 1, 2005, Pages 7-8

  Tovo, Luís Fernando Requeijo ^a   Belfort, Francisco Aparecido ^a   Sanches Jr , José Antônio ^a  

^a Sociedade Brasileira de Dermatologia ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; MELANOMA; PATHOLOGY; REVIEW; SKIN TUMOR;

EVIDENCE-BASED MEDICINE; HUMANS; MELANOMA; SKIN NEOPLASMS;

EID: 33644670828     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302005000100010     Document Type: Note

References (34)

1. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001; 45:579-86.
2. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001; 19:3635-48.
3. The National Comprehensive Cancer Network. Practice Guidelines in Oncology. Melanoma. Version 1. 2002.
4. Lees VC, Briggs JC. Effect of initial biopsy on prognosis in stage I invasive cutaneous malignant melanoma: review of 1086 patients. Br J Surg 1991; 78:1108-10.
5. Lederman JS, Sober AJ. Does biopsy influence sur vival in clinical stage I melanoma. J Am Acad Dermatol 1985; 13:983-7.
6. Austin JR, Byers RM, Brown WD, Wolf P. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck 1996; 18:107-17
7. Ho VC, Sober AJ, Balch CM. Biopsy Techniques. In: Balch CM, Houghton NA, Sober AJ, Soong SJ, editors. Cutaneous melanoma. 3 rd ed. St. Louis: Quality Medical Publishing; 1998. p. 135-40.
8. Halpern AC, Schuchter LM. Prognostic models in melanoma. Semin Oncol 1997; 24:S2-7.
9. Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, et al. Predicting ten-year survival of patients with primary cutaneous melanoma. Corroboration of a prognostic model. Cancer 1997; 80:1426-31.
10. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a populationbased study. Cancer 1996; 78:427-32.
11. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77:1303-10.
12. Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 1996; 125:369-75.
13. Corona R, Scio M, Mele A, Ferranti G, Mostaccioli S, Macchini V, et al. Survival and prognostic factors in patients with localized cutaneous melanoma observed between 1980 and 1991 at the Instituto Dermopatico dell' Immacolata in Rome, Italy. Eur J Cancer 1994; 30A:333-8.
14. Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81:1893-1904.
15. Mansson-Brahme E, Carstensen J, Erhardt K, Lagerlof B, Ringborg U, Rutqvist LE, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73:2324-32.
16. Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Prognostic factors for cutaneous melanoma in Vaud, Switzerland. Int J Cancer 1998; 78:315-9.
17. Balch CM, Soong, S, Ross MI, Urist MM, Karakousis CP, Temple WJ, et al. Longterm results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol 2000; 7:87-97.
18. Thorn M, Bergstrom R, Hedblad M, Lagerlof B, Ringborg U, Adami HO. Predictors of late mortality in cutaneous malignant melanoma - a population-based study in Sweden. Int J Cancer 1996; 67:38-44.
19. Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS. Breslow thickness and Clark level in melanoma. Cancer 2000; 88:589-95.
20. Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M. Thick cutaneous melanoma: a reappraisal of prognostic factors. Melanoma Res 2000; 10:153-64.
21. Slominski AS, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC. Malignant Melanoma an update. Arch Pathol Lab Med 2001; 125:1295-306.
22. Khansur T, Sanders J, Das SK. Evaluation of staging work-up in malignant melanoma. Arch Surg 1989; 124:847-9.
23. Iscoe N, Kersey P, Gapski J, Osoba D, From L, DeBoer G, et al. Predictive value of staging patients with clinical stage I malignant melanoma. Plast Recontr Surg 1987; 80:233-9.
24. Zartman GM, Thomas MR, Robinson WA. Metastatic disease in patients with newly diagnosed malignant melanomas. J Surg Oncol 1987; 35:163-4.
25. Buzaid AC, Belfort F. Como estadiar seus pacientes. Melanoma Bol Inf Grupo Bras Melanoma, 1998; 3:1-2.
26. Coit DG. Patient Surveillance, and follow up. In: Balch CM et al. Cutaneous Melanoma. 3rd ed. St. Louis: Quality Medical Publishing; 1998. p. 313-23.
27. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
28. Brady MS, Thayer D. Review of published experience. In: Cody III HS. Sentinel node biopsy. London: Martin Dunitz Ltd; 2002. p. 161-73.
29. Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2 cm versus 5 cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 2000; 89:1495-501.
30. Cascinelli N. Margin of resection in the management of primary melanoma. Semin Surg Oncol 1998; 14:272-5.
31. Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: longterm results of the multinstitutional randomized surgical trial. Ann Surg Oncol 1996; 3:446-52.
32. Hudson DA, Krige JEJ, Grobbelaar AO, Morgan B, Grover R. Melanoma of the face: the safety of narrow excision margins. Scand J Plast Reconstr Hand Surg 1998; 32:97-104.
33. Heaton KM, Sussman JJ, Gershenwald JE, Lee JE, Reintgen DS, Mansfield PF, et al. Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Ann Surg Oncol 1998; 5:322-8.
34. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992; 268:1314-9.